AMD Wields Capital and Pricing Power as Stock Climbs Within Striking Distance of Record

AMD has deployed a two-pronged strategy that sets it apart in the cutthroat AI chip market: the company is simultaneously investing directly in promising AI startups and raising the prices of its graphics processors on established partners. The twin moves — one signaling long-term ecosystem building, the other demonstrating near-term pricing muscle — have propelled the stock to within striking distance of its all-time high.

Shares jumped 5.59% on Monday to €489.45, leaving the chipmaker just 4.35% below the record peak of €511.70 reached only days earlier. The rally extends a blistering run that has seen the stock gain 20.99% over the past 30 days, 156.66% year-to-date, and 325.76% over the past twelve months. Its year low of €114.96, set in early July 2025, now looks distant: the stock has more than quadrupled since then.

The most intriguing development is the company’s pivot from pure supplier to active investor. AMD’s venture arm has taken a direct stake in the Japanese robotaxi developer Turing, which previously relied almost exclusively on Nvidia chips. Turing has now shifted roughly 10% of its AI training workload to AMD graphics processors, drawn by lower costs. The deal illustrates a new pattern: rather than waiting for hyperscalers like Microsoft or Amazon to place orders, AMD is injecting capital into the very startups that will later buy its silicon. The financial contribution from a single small customer like Turing is negligible, but the strategic template — acquiring equity alongside purchase orders — signals a quieter but consequential shift in AMD’s go-to-market approach.

On the pricing front, AMD has informed key board partners including Sapphire, ASUS, XFX, and Vastarmor that its GPU kits — combining the processor core and GDDR memory — will cost roughly 10% more starting in July 2026. The increase stems from the memory market: AMD held prices steady in 2025 thanks to fixed supply contracts that have since expired, exposing the company to rising memory costs. The move inverts the usual industry dynamic: AMD is raising prices ahead of its larger rival. Nvidia has also bumped up the price tags on its RTX 5090 and RTX 5090D V2 flagship cards, but those increases are only now reaching the distribution channel. For end consumers, the impact may be muted because the GPU kit constitutes only part of the overall graphics card cost borne by board partners.

Should investors sell immediately? Or is it worth buying AMD?

The stock’s momentum has been one of the strongest in the semiconductor sector. AMD is among the top performers in the S&P 500 for the first half of 2026, with year-to-date gains of 156.66% — far outpacing Nvidia’s roughly 4% advance over the same period. The rally is underpinned by robust quarterly results and growing market share in AI infrastructure, driven by demand for the Instinct GPU accelerators. The Philadelphia Semiconductor Index climbed more than 3.5% on Monday, led by AMD and Broadcom, as Bank of America analysts dismissed the recent sector pullback as a temporary correction rather than a structural break in AI demand.

Investor attention now trains on AMD’s “Advancing AI” summit in San Francisco, scheduled for late July. Citigroup analysts expect the company to announce a significant new chip customer during the event, along with details on the roadmap for its MI-series AI accelerators. The Turing deal and the GPU price hike both preview the themes likely to dominate that gathering: pricing power sustained by strong demand, and a willingness to use capital to lock in future buyers before Nvidia can.

Technical indicators confirm the stock is operating at elevated but not overheated levels. The 50-day moving average sits 18.98% below the current price, and the gap to the 200-day average has widened to 99.20%, reflecting how sharply the re-rating has compressed into the first half of the year. The 30-day annualized volatility stands at 75.98%, a mathematical signature of a stock that routinely swings 5% or more in a single session. The relative strength index of 58.7 leaves room for further upside before entering overbought territory, though the market capitalisation of €737.89 billion suggests a great deal of good news is already priced in. The median analyst price target of €445.37 now sits 9% below the current share price — a rare inversion that has the market running ahead of sell-side expectations rather than following them.